Idexx Laboratories Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Public

  • Employees
  • 11,000

Employees

  • Stock Symbol
  • IDXX

Stock Symbol

  • Investments
  • 35

  • Share Price
  • $704.23
  • (As of Friday Closing)

Idexx Laboratories General Information

Description

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Contact Information

Website
www.idexx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • One Idexx Drive
  • Westbrook, ME 04092
  • United States
+1 (207)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • One Idexx Drive
  • Westbrook, ME 04092
  • United States
+1 (207)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Idexx Laboratories Stock Performance

As of 13-Nov-2026, Idexx Laboratories’s stock price is $704.23. Its current market cap is $55.5B with 78.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$704.23 $698.02 $500.61 - $769.98 $55.5B 78.8M 568K $14.91

Idexx Laboratories Financials Summary

As of 30-Sep-2026, Idexx Laboratories has a trailing 12-month revenue of $4.66B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 42,037,859 54,926,617 34,544,039 46,906,316
Revenue 4,662,221 4,303,702 3,897,504 3,660,953
EBITDA 1,668,826 1,505,214 1,258,273 1,212,036
Net Income 1,182,191 1,059,464 887,867 845,042
Total Assets 3,707,109 3,350,759 3,293,443 3,259,925
Total Debt 972,963 976,062 986,948 1,067,353
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Idexx Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Idexx Laboratories‘s full profile, request access.

Request a free trial

Idexx Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pe
Diagnostic Equipment
Westbrook, ME
11,000 As of 2025

Waltham, MA
 

Hwaseong, South Korea
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Idexx Laboratories Competitors (32)

One of Idexx Laboratories’s 32 competitors is Revvity, a Corporation company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Revvity Corporation Waltham, MA
BIONOTE Formerly VC-backed Hwaseong, South Korea
Randox Laboratories Corporation Crumlin, United Kingdom
Great Basin Scientific Formerly VC-backed West Valley City, UT
Arkray Corporation Kyoto, Japan
You’re viewing 5 of 32 competitors. Get the full list »

Idexx Laboratories Patents

Idexx Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1144962-S1 Lateral flow device Active 18-Jul-2025
US-20260301924-A1 Methods, systems, and devices for interpreting non-human patient medical images Pending 27-Mar-2025
US-20260301956-A1 Methods, systems, and devices for updating a veterinarian radiology worklist Pending 27-Mar-2025
US-20260185991-A1 Devices for detection and differentiation of renal disease Pending 31-Dec-2024
US-20260188509-A1 Systems and methods for identifying canine hypothyroidism Pending 31-Dec-2024 G16H50/30
To view Idexx Laboratories’s complete patent history, request access »

Idexx Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Idexx Laboratories Investments & Acquisitions (35)

Idexx Laboratories’s most recent deal was a Merger/Acquisition with CoVet. The deal was made on 16-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CoVet 16-Sep-2026 Merger/Acquisition Other Services (B2C Non-Financial)
Greenline Pet 31-Mar-2024 Merger/Acquisition Business/Productivity Software
TECTA-PDS 25-Aug-2022 Merger/Acquisition Electronic Equipment and Instruments
Epocal 12-Jan-2022 Merger/Acquisition Monitoring Equipment
IDEXX Laboratories (Reference Laboratory) 01-Dec-2021 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 35 investments and acquisitions. Get the full list »

Idexx Laboratories ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

14.71 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Idexx Laboratories’s complete esg history, request access »

Idexx Laboratories Exits (2)

Idexx Laboratories’s most recent exit was on 30-Jan-1997 from Acumedia Manufacturers. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Acumedia Manufacturers 30-Jan-1997 Completed
Purisys 22-Aug-1994 Secondary Transaction - Private Completed
To view Idexx Laboratories’s complete exits history, request access »

Idexx Laboratories Affiliates

Subsidiaries (13)

Name Industry Location Year Founded
CoVet Hamilton, Canada 2023
Vet Radar Auckland, New Zealand 2018
Greenline Pet Memphis, TN 2013
Movet (Other Services (B2C Non-Financial) Kuopio, Finland 2008
EzyVet Auckland, New Zealand 2006
You’re viewing 5 of 13 affiliates. Get the full list.  »

Idexx Laboratories FAQs

  • When was Idexx Laboratories founded?

    Idexx Laboratories was founded in 1983.

  • Where is Idexx Laboratories headquartered?

    Idexx Laboratories is headquartered in Westbrook, ME.

  • What is the size of Idexx Laboratories?

    Idexx Laboratories has 11,000 total employees.

  • What industry is Idexx Laboratories in?

    Idexx Laboratories’s primary industry is Diagnostic Equipment.

  • Is Idexx Laboratories a private or public company?

    Idexx Laboratories is a Public company.

  • What is Idexx Laboratories’s stock symbol?

    The ticker symbol for Idexx Laboratories is IDXX.

  • What is the current stock price of Idexx Laboratories?

    As of 13-Nov-2026 the stock price of Idexx Laboratories is $704.23.

  • What is the current market cap of Idexx Laboratories?

    The current market capitalization of Idexx Laboratories is $55.5B.

  • What is Idexx Laboratories’s current revenue?

    The trailing twelve month revenue for Idexx Laboratories is $4.66B.

  • Who are Idexx Laboratories’s competitors?

    Revvity, BIONOTE, Randox Laboratories, Great Basin Scientific, and Arkray are some of the 32 competitors of Idexx Laboratories.

  • What is Idexx Laboratories’s annual earnings per share (EPS)?

    Idexx Laboratories’s EPS for 12 months was $14.91.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process